SUBSCRIBERS
Corporate digest
Published Fri, Nov 23, 2018 · 09:50 PM
Acromec
ACROMEC, a specialist engineering firm, said that the group is expected to report losses for fiscal 2018. This period refers to the 12 months ended Sept 30, 2018. The loss is due to additional cost in the construction of a pharmaceutical plant in Tuas, it said.
Shares of Acromec last traded at S$0.135.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance